List of Tables

Table 1. Levodopa and Benserazide Hydrochloride Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Levodopa and Benserazide Hydrochloride Market Restraints

Table 3. Levodopa and Benserazide Hydrochloride Market Trends

Table 4. Levodopa and Benserazide Hydrochloride Industry Policy

Table 5. Global Levodopa and Benserazide Hydrochloride Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Levodopa and Benserazide Hydrochloride Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Levodopa and Benserazide Hydrochloride Sales Quantity by Company, (2020-2025) & (Kg), Ranked Based on Sales in 2024

Table 8. Global Levodopa and Benserazide Hydrochloride Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Levodopa and Benserazide Hydrochloride Average Selling Price (ASP) by Company, (2020-2025) & (US$/g)

Table 10. Global Levodopa and Benserazide Hydrochloride Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Levodopa and Benserazide Hydrochloride Mergers & Acquisitions, Expansion Plans

Table 12. Global Levodopa and Benserazide Hydrochloride Manufacturers Product Type

Table 13. Head Office and Levodopa and Benserazide Hydrochloride Production Site of Key Manufacturer

Table 14. Levodopa and Benserazide Hydrochloride Capacity of Major Manufacturers and Future Plan

Table 15. China Levodopa and Benserazide Hydrochloride Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Levodopa and Benserazide Hydrochloride Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Levodopa and Benserazide Hydrochloride Sales Quantity by Company, (2020-2025) & (Kg), Ranked Based on Sales in 2024

Table 18. China Levodopa and Benserazide Hydrochloride Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Levodopa and Benserazide Hydrochloride Production & Forecast by Region, 2020 VS 2024 VS 2031, (Kg)

Table 20. Global Levodopa and Benserazide Hydrochloride Production by Region, 2020-2025, (Kg)

Table 21. Global Levodopa and Benserazide Hydrochloride Production Forecast by Region, 2026-2031, (Kg)

Table 22. Global Key Players of Levodopa and Benserazide Hydrochloride Upstream (Raw Materials)

Table 23. Global Levodopa and Benserazide Hydrochloride Typical Customers

Table 24. Levodopa and Benserazide Hydrochloride Typical Distributors

Table 25. by Type, Global Levodopa and Benserazide Hydrochloride Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Levodopa and Benserazide Hydrochloride Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Levodopa and Benserazide Hydrochloride Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Levodopa and Benserazide Hydrochloride Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Table 30. By Country, Global Levodopa and Benserazide Hydrochloride Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Levodopa and Benserazide Hydrochloride Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Levodopa and Benserazide Hydrochloride Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Table 34. By Country, Global Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2020-2031

Table 35. Alfresa Pharma Company Information, Head Office, Market Area, and Industry Position

Table 36. Alfresa Pharma Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 37. Alfresa Pharma Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 38. Alfresa Pharma Company Profile and Main Business

Table 39. Alfresa Pharma Recent Developments

Table 40. Devatis Company Information, Head Office, Market Area, and Industry Position

Table 41. Devatis Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 42. Devatis Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 43. Devatis Company Profile and Main Business

Table 44. Devatis Recent Developments

Table 45. Kyowa Kirin Company Information, Head Office, Market Area, and Industry Position

Table 46. Kyowa Kirin Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 47. Kyowa Kirin Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 48. Kyowa Kirin Company Profile and Main Business

Table 49. Kyowa Kirin Recent Developments

Table 50. Neuraxpharm Arzneimittel Company Information, Head Office, Market Area, and Industry Position

Table 51. Neuraxpharm Arzneimittel Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 52. Neuraxpharm Arzneimittel Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 53. Neuraxpharm Arzneimittel Company Profile and Main Business

Table 54. Neuraxpharm Arzneimittel Recent Developments

Table 55. Roche Pharma Company Information, Head Office, Market Area, and Industry Position

Table 56. Roche Pharma Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 57. Roche Pharma Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 58. Roche Pharma Company Profile and Main Business

Table 59. Roche Pharma Recent Developments

Table 60. Taiyo Holdings Company Information, Head Office, Market Area, and Industry Position

Table 61. Taiyo Holdings Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 62. Taiyo Holdings Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 63. Taiyo Holdings Company Profile and Main Business

Table 64. Taiyo Holdings Recent Developments

Table 65. Teva Pharmaceutical Industries Company Information, Head Office, Market Area, and Industry Position

Table 66. Teva Pharmaceutical Industries Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 67. Teva Pharmaceutical Industries Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 68. Teva Pharmaceutical Industries Company Profile and Main Business

Table 69. Teva Pharmaceutical Industries Recent Developments

Table 70. Aida Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 71. Aida Pharmaceutical Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 72. Aida Pharmaceutical Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 73. Aida Pharmaceutical Company Profile and Main Business

Table 74. Aida Pharmaceutical Recent Developments

Table 75. Baiyunshan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 76. Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 77. Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 78. Baiyunshan Pharmaceutical Company Profile and Main Business

Table 79. Baiyunshan Pharmaceutical Recent Developments

Table 80. Fuda Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 81. Fuda Pharmaceutical Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 82. Fuda Pharmaceutical Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 83. Fuda Pharmaceutical Company Profile and Main Business

Table 84. Fuda Pharmaceutical Recent Developments

Table 85. Xinhua Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 86. Xinhua Pharmaceutical Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 87. Xinhua Pharmaceutical Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 88. Xinhua Pharmaceutical Company Profile and Main Business

Table 89. Xinhua Pharmaceutical Recent Developments

Table 90. Yishengyuan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 91. Yishengyuan Pharmaceutical Levodopa and Benserazide Hydrochloride Models, Specifications, and Application

Table 92. Yishengyuan Pharmaceutical Levodopa and Benserazide Hydrochloride Sales Quantity (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 93. Yishengyuan Pharmaceutical Company Profile and Main Business

Table 94. Yishengyuan Pharmaceutical Recent Developments

List of Figures

Figure 1. Levodopa and Benserazide Hydrochloride Picture

Figure 2. Global Levodopa and Benserazide Hydrochloride Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Levodopa and Benserazide Hydrochloride Sales Quantity, (Kg) & (2020-2031)

Figure 4. Global Levodopa and Benserazide Hydrochloride Average Selling Price (ASP), (2020-2031) & (US$/g)

Figure 5. China Levodopa and Benserazide Hydrochloride Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Levodopa and Benserazide Hydrochloride Sales Quantity (Kg) & (2020-2031)

Figure 7. China Levodopa and Benserazide Hydrochloride Average Selling Price (ASP), (US$/g) & (2020-2031)

Figure 8. By Consumption Value, China Levodopa and Benserazide Hydrochloride Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Levodopa and Benserazide Hydrochloride Market Share of Global, 2020-2031

Figure 10. Global Levodopa and Benserazide Hydrochloride Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Levodopa and Benserazide Hydrochloride Key Participants, Market Share, 2024

Figure 12. Global Levodopa and Benserazide Hydrochloride Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Levodopa and Benserazide Hydrochloride Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Levodopa and Benserazide Hydrochloride Production Market Share & Forecast by Region, 2020-2031

Figure 15. Levodopa and Benserazide Hydrochloride Industry Chain

Figure 16. Levodopa and Benserazide Hydrochloride Procurement Model

Figure 17. Levodopa and Benserazide Hydrochloride Sales Model

Figure 18. Levodopa and Benserazide Hydrochloride Sales Channels, Direct Sales, and Distribution

Figure 19. Capsules

Figure 20. Tablets

Figure 21. Granules

Figure 22. by Type, Global Levodopa and Benserazide Hydrochloride Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Levodopa and Benserazide Hydrochloride Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 25. by Type, Global Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Levodopa and Benserazide Hydrochloride Average Selling Price (ASP), 2020-2031, (US$/g)

Figure 27. Parkinson's Disease

Figure 28. Symptomatic Parkinsonism

Figure 29. by Application, Global Levodopa and Benserazide Hydrochloride Consumption Value, 2020-2031, US$ Million

Figure 30. by Application, Global Levodopa and Benserazide Hydrochloride Revenue Market Share, 2020-2031

Figure 31. by Application, Global Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 32. by Application, Global Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2020-2031

Figure 33. by Application, Global Levodopa and Benserazide Hydrochloride Price, 2020-2031, (US$/g)

Figure 34. By Region, Global Levodopa and Benserazide Hydrochloride Consumption Value Market Share, 2020-2031

Figure 35. By Region, Global Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2020-2031

Figure 36. North America Levodopa and Benserazide Hydrochloride Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 37. By Country, North America Levodopa and Benserazide Hydrochloride Consumption Value Market Share, 2024

Figure 38. Europe Levodopa and Benserazide Hydrochloride Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 39. By Country, Europe Levodopa and Benserazide Hydrochloride Consumption Value Market Share, 2024

Figure 40. Asia Pacific Levodopa and Benserazide Hydrochloride Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country/Region, Asia Pacific Levodopa and Benserazide Hydrochloride Consumption Value Market Share, 2024

Figure 42. South America Levodopa and Benserazide Hydrochloride Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, South America Levodopa and Benserazide Hydrochloride Consumption Value Market Share, 2024

Figure 44. Middle East & Africa Levodopa and Benserazide Hydrochloride Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. United States Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 46. by Type, United States Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 47. by Application, United States Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 48. Europe Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 49. by Type, Europe Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 50. by Application, Europe Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 51. China Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 52. by Type, China Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, China Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 54. Japan Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 55. by Type, Japan Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, Japan Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 57. South Korea Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 58. by Type, South Korea Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, South Korea Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 60. Southeast Asia Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 61. by Type, Southeast Asia Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, Southeast Asia Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 63. India Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 64. by Type, India Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, India Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 66. Middle East & Africa Levodopa and Benserazide Hydrochloride Sales Quantity, 2020-2031, (Kg)

Figure 67. by Type, Middle East & Africa Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, Middle East & Africa Levodopa and Benserazide Hydrochloride Sales Quantity Market Share, 2024 VS 2031

Figure 69. Research Methodology

Figure 70. Breakdown of Primary Interviews

Figure 71. Bottom-up Approaches

Figure 72. Top-down Approaches